【摘要】 鼻咽癌是我国一种常见的恶性程度高、发展快、转移早的癌瘤。肿瘤部位的隐蔽或取活检组织技术的差异,使鼻咽癌患者往往难以得到早期的病理组织学确诊。EBV-VCA-IgA的检测已被公认是鼻咽癌早期发现、早期诊断、预后监测及大规模普查的敏感、可靠、简便的方法[1]。我们自1985年开展免疫酶法EBV-VCA-IgA捡测至今,共检测了1982份血清标本。通过实践我们体会到,EBV-VCA-IgA的捡测若能很好的与病理组织学检查结合起来,将是提高鼻咽癌早期确诊率的有效途径。更多还原

【Abstract】 As we all know, cancer and EBV close. Nasopharyngeal carcinoma is a common malignancy, rapid development, early metastasis of cancer. The concealment or tumor biopsy site technical differences, nasopharyngeal cancer patients often make it difficult to achieve the early histologic diagnosis. EBV-VCA-IgA detection has been recognized as nasopharyngeal cancer early detection, early diagnosis, prognosis and large-scale census sensitive, reliable and convenient way[1]. Since 1985, we carried out immunohistochemical test so far seized enzymatic EBV-VCA-IgA, A total of 1982 serum samples. Through practice, we understand, EBV-VCA-IgA seized if measured with a good combination of histologic examination, will be an effective way to improve the rate of early diagnosis of nasopharyngeal carcinoma.更多还原